Effect of intensive versus moderate lipid lowering on endothelial function and vascular responsiveness to angiotensin II in stable coronary artery disease

American Journal of Cardiology

Volumn 96, Issue 10, 2005, Pages 1361-1364

  Van Der Harst, Pim ^a   Wagenaar, Lodewijk J ^b   Buikema, Hendrik ^a   Voors, Adriaan A ^a   Plokker, H W Thijs ^b   Morshuis, Wim J ^b   Six, A Jacob ^c   Boonstra, Piet W ^a   Nickenig, Georg ^d   Wassmann, Sven ^d   Van Veldhuisen, Dirk J ^a   Van Gilst, Wiek H ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b ST ANTONIUS HOSPITAL   (Netherlands)

^c Zuwe Hofpoort Ziekenhuis   (Netherlands)

^d SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANTICOAGULANT AGENT; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; NITRATE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; ENDOTHELIUM CELL; EVIDENCE BASED MEDICINE; FEMALE; HUMAN; INTERNAL MAMMARY ARTERY; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VASODILATATION;

AGED; ANGIOTENSIN II; ANTILIPEMIC AGENTS; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY BYPASS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; ENDOTHELIUM, VASCULAR; FEMALE; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MAMMARY ARTERIES; MIDDLE AGED; PROSPECTIVE STUDIES; PYRROLES; TREATMENT OUTCOME; VASODILATION;

EID: 27644493202     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2005.07.052     Document Type: Article

References (12)

1. J.C. LaRosa, S.M. Grundy, D.D. Waters, C. Shear, P. Barter, J.C. Fruchart, A.M. Gotto, H. Greten, J.J. Kastelein, J. Shepherd, N.K. Wenger Intensive lipid lowering with atorvastatin in patients with stable coronary disease N Engl J Med 352 2005 1425 1435
2. C.B. Treasure, J.L. Klein, W.S. Weintraub, J.D. Talley, M.E. Stillabower, A.S. Kosinski, J. Zhang, S.J. Boccuzzi, J.C. Cedarholm, R.W. Alexander Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease N Engl J Med 332 1995 481 487
3. G. Nickenig, A. Sachinidis, F. Michaelsen, M. Bohm, S. Seewald, H. Vetter Upregulation of vascular angiotensin II receptor gene expression by low-density lipoprotein in vascular smooth muscle cells Circulation 95 1997 473 478
4. G. Nickenig, A.T. Baumer, Y. Temur, D. Kebben, F. Jockenhovel, M. Bohm Statin-sensitive dysregulated AT1 receptor function and density in hypercholesterolemic men Circulation 100 1999 2131 2134
5. M. Oosterga, A.A. Voors, H. Buikema, Y.M. Pinto, H.E. Haber, T. Ebels, W.J. Morshuis, J.H. Kingma, H.J. Crijns, W.H. van Gilst QUO VADIS Investigators Angiotensin II formation in human vasculature after chronic ACE inhibition a prospective, randomized, placebo-controlled study Cardiovasc Drugs Ther 14 2000 55 60
6. H. Buikema, J.G. Grandjean, S. van den Broek, W.H. van Gilst, K.I. Lie, H. Wesseling Differences in vasomotor control between human gastroepiploic and left internal mammary artery Circulation 86 1992 II205 II209
7. M. Feelisch The biochemical pathways of nitric-oxide formation from nitrovasodilators - appropriate choice of exogenous no donors and aspects of preparation and handling of aqueous no solutions J Cardiovasc Pharmacol 17 1991 S25 S33
8. U. Laufs, F.V. La, J. Plutzky, J.K. Liao Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors Circulation 97 1998 1129 1135
9. O. Hernandez-Perera, D. Perez-Sala, J. Navarro-Antolin, R. Sanchez-Pascuala, G. Hernandez, C. Diaz, S. Lamas Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells J Clin Invest 101 1998 2711 2719
10. J.A. Vita, C.B. Treasure, E.G. Nabel, J.M. McLenachan, R.D. Fish, A.C. Yeung, V.I. Vekshtein, A.P. Selwyn, P. Ganz Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease Circulation 81 1990 491 497
11. F.W. Asselbergs, P. van der Harst, G.A. Jessurun, R.A. Tio, W.H. van Gilst Clinical impact of vasomotor function assessment and the role of ACE-inhibitors and statins Vasc Pharmacol 42 2005 125 140
12. C. Yan, D. Kim, T. Aizawa, B.C. Berk Functional interplay between angiotensin II and nitric oxide cyclic GMP as a key mediator Arterioscler Thromb Vasc Biol 23 2003 26 36